Summary
In order to improve our ability to predict the regrowth of nonfunctioning pituitary adenomas, we tried to assess the correlation between growth fractions with Ki-67 and PCNA (proliferating cell nuclear antigen) and tumour doubling times in regrowing tumours, and also to find out any difference of growth fractions between the regrowing and the cured cases.
In 33 patients with non-functioning pituitary adenomas, 14 cases including 11 with cavernous sinus invasion showed residual tumour on MRI after the operation (regrowing group) and 19 cases had no tumour regrowth on MRI within 5 years after the operation (cured group). Immunocytochemical studies were done with monoclonal antibodies (anti-PCNA, anti-Ki-67: MIB-1). The growth fraction of each tumour was estimated by calculating the ratio of the positive nuclei to the total number of tumour cells with the aid of an image analyser (Mac SCOPE). The tumour doubling times were estimated from serial CT or MRI with the aid of the image analyser (NIH image).
Ki-67 staining indices ranged from 0.2% to 1.5% (n = 14, 0.86±0.10%; mean±SEM) in the regrowing group, and from 0.1% to 0.5% (n = 19, 0.23±0.03%) in the cured group. PCNA staining indices of the regrowing group ranged from 0.6% to 24% (n = 14, 3.7±1.6%). In the regrowing group, the tumour doubling times ranged from 200 to 2550 days (930±180 days), and showed a significant inverse correlation with Ki-67 staining indices, but no correlation with PCNA staining indices. The regrowing group showed a significantly higher Ki-67 staining index (n = 14, 0.86±0.10%) than the cured group (n = 19, 0.23±0.03%) (p<0.01).
These results indicate that immunocytochemical studies using MIB-1 may be better than those with PCNA for the prediction of regrowth in non-functioning pituitary adenomas. Immunocytochemical study with MIB-1 could lead to the accurate prediction of the rapid regrowing lesions in non-functioning adenomas.
Similar content being viewed by others
References
Anniko M, Holm L-E, Wersäll J (1983) Aggressive pituitary tumor growth. Arch Otorhinolaryngol 238: 53–62
Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67: its use in histopathology. Histopathology 17: 489–503
Burger PC, Shibata T, Kleihues P (1986) The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol 10: 611–617
Cho KG, Hoshino T, Nagashima T, Murovic JA, Wilson CB (1986) Prediction of tumor doubling time in recurrent meningiomas. J Neurosurg 65: 790–794
Ciric I, Mikhael M, Stafford T, Lawson L, Garces R (1983) Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59: 395–401
Ebersold MJ, Quast LM, Laws ER, Scheithauer B, Randall RV (1986) Long-term results in transsphenoidal removal of non-functioniong pituitary adenomas. J Neurosurg 64: 713–719
Ekramullah SM, Saitoh Y, Ohnishi T, Arita N, Taki T, Hayakawa T (1995) Effects of bromocriptine on staining indices of Ki-67 and proliferating cell nuclear antigen, and nucleolar organizer region number in pituitary adenomas. Neurol Med Chir (Tokyo) 35: 221–226
Falini B, Canino S, Sacchi S, Ciani C, Martelli MF, Gerdes J, Stein H, Pileri S, Gobbi M, Fagioli M, Minelli O, Flenghi L (1988) Immunocytochemical evaluation of the percentage of proliferating cells in pathological bone marrow and peripheral blood samples with the Ki-67 and anti-bromo-deoxyuridine monoclonal antibodies. Br J Haematol 69: 311–320
Gerdes J, Becker MHG, Key G (1992) Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168: 85–87
Hall PA, Levison DA, Woods AL, Yu CC-W, Kellock DB, Watkins JA, Barnes DM, Gillett CE, Camplejohn R, Dover R, Waseem NH, Lane DP (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285–294
Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W (1980) Silent corticotrophic adenomas of the pituitary gland. A histologie, immunocytologic and ultrastructural study. Am J Pathol 98: 617–638
Hsu DW, Hakim F, Biller BMK, Monte SDL, Zervas NT, Klibanski A, Hedley-Whyte ET (1993) Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78: 753–761
Kamel OW, Franklin WA, Ringus JC, Meyer JS (1989) Thymidine labelling index and Ki-67 growth fraction in lesions of the breast. Am J Pathol 134: 107–113
Karamitopoulou E, Perentes E, Melachrinou M, Maraziotis T (1993) Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropathol 85: 316–322
Knosp E, Kitz K, Perneczky A (1989) Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25: 927–930
Landolt AM, Shibata T, Kleihues P (1987) Growth rate of human pituitary adenomas. J Neurosurg 67: 803–806
May PL, Broome JC, Lawry J, Buxton RA, Battersby RDE (1989) The prediction of recurrence in meningiomas: a flow cytpmetric study of paraffin-embedded archival material. J Neurosurg 71: 347–351
Nagashima T, Murovic JA, Hoshino T, Wilson CB, DeArmond SJ (1986) The proliferative potential of human pituitary tumors in situ. J Neurosurg 64: 588–593
Nishizaki T, Orita T, Furutani Y, Ikeyama Y, Aoki H, Sasaki K (1989) Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdR labelling indices in human brain tumors. J Neurosurg 70: 379–384
Rowlands DC, Brown HE, Barber PC, Jones EL (1991) The effect of tissue fixation on immunostaining for proliferating cell nuclear antigen with the monoclonal antibody PC10. J Pathol 165: 356–357
Sabattini E, Gerdes J, Gherlinzoni F, Poggi S, Zucchini L, Melilli G, Grigioni F, Del Vecchio MT, Leoncini L, Falini B, Pileri SA (1993) Comparison between the monoclonal antibodies Ki-67 and PC10 in 125 malignant lymphomas. J Pathol 169: 397–403
Sasaki M, Matsumura K, Tsuji T, Shinozaki F, Takahashi M (1988) Relationship between labelling indices of Ki-67 and BrdUrd in human malignant tumors. Cancer 62: 989–993
Scheithauer BW, Kovacs KT, Laws ERJ, Randall RV (1986) Pathology of invasive pituitary tumours with special reference to functional classification. J Neurosurg 65: 733–744
Schiffer D, Chiò A, Giordana MT, Pezzulo T, Vigliani MC (1993) Proliferating cell nuclear antigen expression in brain tumors, and its prognostic role in ependymomas: an immunohistochemical study. Acta Neuropathol 85: 495–502
Schrape S, Jones DB, Wright DH (1987) A comparison of three methods for the determination of the growth fraction in non-Hodgkin's lymphoma. Br J Cancer 55: 283–286
Schwarting R, Gerdes J, Niehus J, Jaeschke L, Stein H (1986) Determination of the growth fraction in cell suspensions by flow cytometry using the monoclonal antibody Ki-67. J Immunol Methods 90: 65–70
Selman WR, Laws ERJ, Scheithauer BW, Carpenter SM (1986) The occurrence of durai invasion in pituitary adenomas. J Neurosurg 64: 402–407
Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T (1992) Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labelling, and nuclear organizer region counts. Acta Neuropathol 84: 178–183
Silvestrini R, Costa A, Veneroni S, Del Bino G, Persici P (1988) Comparative analysis of different approaches to investigate cell kinetics. Cell Tissue Kinet 21: 123–131
Taki T, Ohnishi T, Arita N, Hiraga S, Saitoh Y, Izumoto S, Mori K, Hayakawa T (1994) Anti-proliferative effects of TNP-470 on human malignant glioma in vivo: potent inhibition of tumor angiogenesis. J Neurooncol 19: 251–258
Tubiana M, Pejovic MH, Koscielny S, Chavaudra N, Malaise E (1989) Growth rate, kinetics of tumor cell proliferation and long-term outcome in human breast cancer. Int J Cancer 44: 17–22
Veneroni S, Costa A, Motta R, Giardini R, Rilke F, Silvestrini R (1988) Comparative analysis of [3H]-thymidine labelling index and monoclonal antibody Ki-67 in non-Hodgkin's lymphomas. Hematol Oncol 6: 21–28
Walker RA, Camplejohn RS (1988) Comparison of monoclonal antibody Ki-67 reactivity with grade and DNA flow cytometry of breast carcinomas. Br J Cancer 57: 281–283
Wersto RP, Herz F, Gallagher RE, Koss LG (1988) Cell cycle-dependent reactivity with the monoclonal antibody Ki-67 during myeloid cell differentiation. Exp Cell Res 179: 79–88
Wolf HK, Dittrich KL (1992) Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 40: 1269–1273
Yamashita T, Kuwabara T (1983) Estimation of rate of growth of malignant brain tumors by computed tomography scanning. Surg Neurol 20: 464–470
Yu CC-W, Woods AL, Levison DA (1992) The assessment of cellular proliferation by immunohistochemistry: a review of currently available methods and their applications. Histochem J 24: 121–131
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ekramullah, S.M., Saitoh, Y., Arita, N. et al. The correlation of Ki-67 staining indices with tumour doubling times in regrowing non-functioning pituitary adenomas. Acta neurochir 138, 1449–1455 (1996). https://doi.org/10.1007/BF01411125
Issue Date:
DOI: https://doi.org/10.1007/BF01411125